department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

when

Latest
Archive

by source

All Sources
Sources Page

by activity

Most Active
Biggest Pipelines
Recently Active

hiring

Companies Hiring Now
Big Pharma Roles
All Companies →

Drugs & Pipeline

intelligence

Drugs
Patent Cliff

research

Publications
Topics

window

Next 90 Days
All (incl. Past)

by type

PDUFAs
Approvals
Earnings
Readouts

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Calendar
Drugs
Companies
News

Hubs

Topics
Jobs
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
cal
search

Vistagen Therapeutics, Inc. ($VTGN) · pharmadog

PUBLIC COMPANY

$VTGNVistagen Therapeutics, Inc.

South San Francisco, CA, USupdated 1mo ago

SEC EDGAR ↗Yahoo Finance ↗

community read0 votes

pipeline

5

marketed

0

phase 3

1

catalysts ytd

0

approvals ytd

0

recalls ytd

0

Pipeline(5)

pipeline depth5 products

4Phase 21Phase 3

Social Anxiety Disorder (SAD/Social Phobia)

Major Depressive Disorder

Glutamate [NMDA] receptor

Phase 2

PH-15

Cognitive Impairment

Major Depressive Disorder

Premenstrual Dysphoric Disorder (PMDD)

Upcoming

no upcoming catalysts on record

Recent(90d)

nothing in the last 90 days

view all catalysts →

🐶 Hiring Signal

No open roles indexed yet — view Vistagen Therapeutics, Inc. jobs →

News

no news has mentioned this company yet

identifiers

ticker

$VTGN

SEC CIK

0001411685

country

US

source

sec_tickers

top tags

Major Depression2 Women's Health1

mentioned in

0news items

entity-linker matched

$VTGN

Data sources

last refreshed 2m ago

Found something off?

🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

Active trials

phase3Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder (PALISADE-4)recruitingn=236
phase2PH94B in the Treatment of Adjustment Disorder With Anxietycompletedn=41
phase2A Clinical Trial to Assess the Efficacy, Safety, and Tolerability of a Repeat Dose of Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorderrecruitingn=60
phase3Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder (PALISADE-3)active not recruitingn=238
phase3PH94B Nasal Spray for Anxiety Induced by a Public Speaking Challenge - 2terminatedn=228
phase3Open-label Safety Trial of PH94B in Social Anxiety Disorder (SAD)terminatedn=481
phase3PH94B Nasal Spray for Anxiety Induced by a Public Speaking Challengecompletedn=224

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

Insider activity

source: SEC Form 4

routine RSU / option mechanics (6)

Apr 7, 26grantTressler Nick B. · Chief Financial Officer75,000 sh
Apr 7, 26grantSingh Shawn · President and CEO3,732 sh
Apr 7, 26grantSingh Shawn · President and CEO71,268 sh
Apr 7, 26grantPrince Joshua S. · Chief Operating Officer18,752 sh
Apr 7, 26grantPrince Joshua S. · Chief Operating Officer56,248 sh
Apr 7, 26grantCote Elissa S. · Chief Corp Development Officer75,000 sh